The abstract is read at the publisher; the summary is JClub's.
Surfactant protein D (SP-D) is elevated in systemic sclerosis-related interstitial lung disease (SSc-ILD), with 17.36 ± 11.99 ng/mL versus 9.49 ± 7.92 ng/mL in SSc-NoILD.
- Why it matters: Clinicians lack validated blood biomarkers to identify SSc-ILD and to stratify risk for progressive pulmonary fibrosis in systemic sclerosis.
- What they did: Plasma proteomics quantified 1507 proteins in 202 patients with systemic sclerosis across discovery (n = 45) and replication (n = 157) cohorts, then used ELISA to validate candidates; SP-D and MMP-8 were tested across multicenter groups.
- The result: SP-D distinguished SSc-ILD from SSc-NoILD (P < .0001), while MMP-8 was higher in SSc-PPF versus SSc-NoPPF (17.67 ± 12.45 vs 10.77 ± 10.92 ng/mL; P < .001) and independently predicted SSc-PPF, with replication in a 113-patient Tokyo/Milan cohort.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.